Published by Frank Prenesti on 7th March 2025
(Sharecast News) - AstraZeneca said its Imfinzi drug when used with chemotherapy had shown "statistically significant and clinically meaningful improvement" in survival in resectable early-stage gastric and gastroesophageal cancers before surgery.
URL: http://www.digitallook.com/dl/news/story/34927086/...